Yifeng
Yifeng Pharmacy Chain Co., Ltd. engages in pharmaceutical retail business in China.
Yifeng, founded in June, 2008 and headquartered in Changde, is a national large-scale pharmaceutical retail chain enterprise. The founder is Gao Yi. Listed on the SSE on February 17, 2015, the company's major shareholders are Ningbo Meishan Bonded Port Zone Jikang Enterprise Management Partnership (LP), Hong Kong Central Clearing Co., Ltd. and Gao Yi. Rivals that have direct and indirect competition with Yifeng include 111 Group, JD health, Glaxo Smith Kline, Pfizer, etc.
Rice ball takeout has officially entered the Australian market, and high-quality takeout services have captured overseas food
Growing Demand for Imported Food in China — Flesh Out Challenges and Opportunities
Over centuries, people are on the hunt for good foods as a fundamental consumer staple around the world. With access to a variety of nutritious food, the global food system inevitably reduces malnutrition in different countries, with a huge leap in agricultural productivity and international trade. Imported food from foreign countries seems like an unavoidable option to reverse the monotonous biodiversity and growing problem with pests and diseases.
May 06, 2022 03:06 AM
Robosen completed round B and round B + financing of nearly US $100 million
The new brand Hutou Bureau has signed a strategic cooperation with tmall. In the future, heavy new products will be launched in tmall
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Real Estate, Industrials, TechnologyTech for Global, Globalization Footprints of the Established and the New
Happy cake has completed a new round of financing of RMB 100 million, led by Asian business capital and followed by Chunjian capital. The listing plan will be launched in the future
Weixiaofan, a new digital fast food brand, has completed a round of financing of nearly 100 million yuan, with Tiantu's exclusive investment
Jingdong double 11 was fully opened, and 190 million goods were sold in 4 hours
Yuntianhua: the shareholder completed the reduction of 2% of the shares with the investment of Yuntianhua
ATRenew's Net Revenue Increased by 45.7% YoY in Q1 2022
AtRenew had a huge growth in Q1 2022, with successful increases in numbers of several sections listed in the Financial Report for this quarter. ATRenew's future plan showed its differences compared with others and implied its high potential to grow in the future.
May 25, 2022 08:56 PM
"Odor library" completed round B financing and Puig entered the market to accelerate the outbreak of the brand
Pinduoduo generates profit while continuing strong growth
Tencent Q2's profit growth slowed down, and its social value strategy was integrated into the company's organizational power and action power
Tide play digital IP brand "gravity planet gravistar" won an angel round investment of nearly ten million yuan from Qingsong fund
Alibaba beats profit expectations but misses revenue expectations
New capital helps Yunnan Xiaobao spac go public
Yifeng: Xiao Zaixiang, the Vice President, Intends to Sell Shares